IMVT
Immunovant Inc

2,211
Mkt Cap
$5.27B
Volume
1.13M
52W High
$27.80
52W Low
$12.72
PE Ratio
-9.19
IMVT Fundamentals
Price
$26.01
Prev Close
$26.18
Open
$26.06
50D MA
$24.93
Beta
0.98
Avg. Volume
1.89M
EPS (Annual)
-$2.73
P/B
8.73
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Immunovant (NASDAQ:IMVT) CTO Jay Stout Sells 1,977 Shares
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) CTO Jay Stout sold 1,977 shares of Immunovant stock in a transaction on Wednesday, January 21st. The shares were sold at an average price of $26.03...
MarketBeat·9h ago
News Placeholder
More News
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Receives Average Rating of "Moderate Buy" from Brokerages
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven ratings firms that are presently covering the company, Marketbeat.com reports. One...
MarketBeat·21h ago
News Placeholder
SG Americas Securities LLC Has $1.01 Million Stock Holdings in Immunovant, Inc. $IMVT
SG Americas Securities LLC raised its stake in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 679.7% in the third quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·5d ago
News Placeholder
Immunovant (NASDAQ:IMVT) Stock Price Down 5.7% - Should You Sell?
Immunovant (NASDAQ:IMVT) Stock Price Down 5.7% - Should You Sell...
MarketBeat·8d ago
News Placeholder
How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%
The mean of analysts' price targets for Immunovant (IMVT) points to a 47.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·9d ago
News Placeholder
Immunovant (NASDAQ:IMVT) CTO Jay Stout Sells 1,203 Shares
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) CTO Jay Stout sold 1,203 shares of the stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $26.53, for a total...
MarketBeat·14d ago
News Placeholder
Immunovant (NASDAQ:IMVT) Price Target Raised to $22.00 at Truist Financial
Truist Financial increased their target price on shares of Immunovant from $16.00 to $22.00 and gave the stock a "hold" rating in a research report on Thursday...
MarketBeat·16d ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Immunovant, Inc. (NASDAQ: IMVT) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...
PR Newswire·19d ago
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eleven ratings firms that are currently covering the firm, Marketbeat...
MarketBeat·26d ago
News Placeholder
Assenagon Asset Management S.A. Invests $3.31 Million in Immunovant, Inc. $IMVT
Assenagon Asset Management S.A. purchased a new position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the third quarter, according to its most recent filing with the Securities...
MarketBeat·1mo ago
<
1
2
...
>

Latest IMVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.